COMPLEX ALLELES OF THE ACID BETA-GLUCOSIDASE GENE IN GAUCHER DISEASE
Authors:
- GA GRABOWSKIGGGA GRABOWSKI
- BDM THEOPHILUSBTBDM THEOPHILUS
- FI SMITHFSFI SMITH
- 1 July 1990
- journal article
- research article
- Vol. 47 (1) , 79-86
Abstract
Gaucher disease is inherited in an autosomal recessive manner and is the most prevalent lysosomal storage disease. Gaucher disease has marked phenotypic variation and molecular heterogeneity, and seven point mutations in the acid .beta.-glucosidase (.beta.-Glc) gene have been identified. By means of sequence-specific oligonucleotides (SSO), mutation 6433C has been detected homozygously in neuronopathic type 2 (acute) and type 3 (subacute) patients, as well as in children with severe visceral involvement who are apparently free of neuronopathic disease. To investigate the molecular basis for this puzzling finding, amplified .beta.-Glc cDNAs from 6433C homozygous type 2 and type 3 Gaucher disease patients were cloned and sequenced. The Swedish type 3 Gaucher disease patient was truly homozygous for alleles only containing the 6433C mutation. In comparison, the type 2 patient contained a singly mutated 6433C allele and a "complex" allele with multiple discrete point mutations (6433C, 6468C, and 6433C). Each of the mutations in the complex allele also was present in the .beta.-Glc pseudogene. SSO hybridization of 6433C homozygotes revealed that both type 2 patients contained additional mutations in one allele, whereas the 6433C alone was detected in both type 3 and in young severe type 1 Gaucher disease patients. These results suggest that the presence of the complex allele influences the severity of neuronopathic disease in 6433C homozygotes and reveal the central role played by the pseudogene in the formation of mutant alleles of the .beta.-Glc gene. Analysis of additional cDNA clones also identified two new alleles in a type 3 patient, emphasizing the molecular heterogeneity of neuronopathic Gaucher disease.Keywords
This publication has 25 references indexed in Scilit:
- Comparison of RNase A, a chemical cleavage and GC-clamped denaturing gradient gel electrophoresis for the detection of mutations in exon 9 of the human acidβ-glucosidase geneNucleic Acids Research, 1989
- Glucocerebrosidase processing in normal fibroblasts and in fibroblasts from patients with type I, type II, and type III Gaucher disease.Proceedings of the National Academy of Sciences, 1986
- Human acid beta-glucosidase: isolation and amino acid sequence of a peptide containing the catalytic site.Proceedings of the National Academy of Sciences, 1986
- Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell AnemiaScience, 1985
- Genetic heterogeneity in Gaucher disease: Physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non‐neuronopathic and neuronopathic patientsAmerican Journal of Medical Genetics, 1985
- Supercoil Sequencing: A Fast and Simple Method for Sequencing Plasmid DNADNA, 1985
- GAUCHER DISEASE TYPE-1, TYPE-2, AND TYPE-3 - DIFFERENTIAL MUTATIONS OF THE ACID BETA-GLUCOSIDASE ACTIVE-SITE IDENTIFIED WITH CONDURITOL-B EPOXIDE DERIVATIVES AND SPHINGOSINE1985
- Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease.Proceedings of the National Academy of Sciences, 1982
- Gaucher disease-norrbottnian typeEuropean Journal of Pediatrics, 1980
- Population study of chronic Gaucher's disease.1973